Trial intelligence / Profile preview

Colla Corii Asini in Pregnant Women with Thalassemia

NCT02772016Phase 1Unknown

Start
Mar 2015
Primary completion
May 2016
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 1, randomised, open-label trial of colla corii asini in beta thalassemia and anemia (2 arms). Primary endpoints: Hemoglobin at 4 weeks, Adult hemoglobin at 4 weeks and 2 more. Status: unknown.

02

Drugs

colla corii asini
03

Conditions

beta thalassemiaanemia

Beyond the preview

Go deeper on NCT02772016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02772016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call